{'fraction_non_alphanumeric': 0.013297872340425532, 'fraction_numerical': 0.010638297872340425, 'mean_word_length': 4.984126984126984, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
DNA Test for Breast Cancer Risk Draws Criticism

Last week, deCODE Genetics released the first-ever breast cancer risk test designed to cover common forms of the disease. Many oncologists and geneticists decried the $1625 test as premature because it includes just seven genetic variants out of the dozens or hundreds driving breast cancer that scientists expect to find soon.